INNOVATION PHARMACEUTICAL (IPIX) Debt by Year
INNOVATION PHARMACEUTICAL held $1.5M in cash and equivalents at the end of fiscal year 2023, and long-term debt is not reported for that period. The table below carries 15 fiscal years, from 2009 to 2023, and the quarters INNOVATION PHARMACEUTICAL has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
IPIX Debt & Cash by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K | FY1110-K | FY1010-K | FY0910-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash & Equivalents | $1.5M-60.1% | $3.8M-62.7% | $10.2M+69.4% | $6.0M+939.4% | $579K-76.1% | $2.4M-41.5% | $4.1M | $0 | $0 | $0 | $0-100.0% | $28K-58.8% | $68K+1602.6% | $4K | N/A |
IPIX Debt & Cash by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q1'2410-Q | Q4'2310-Q | Q3'2310-Q | Q2'2310-Q | Q1'2310-Q | Q4'2210-K | Q3'2210-Q | Q2'2210-Q | Q1'2210-Q | Q4'2110-K | Q3'2110-Q | Q2'2110-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash & Equivalents | $864K-70.9% | $1.5M-60.1% | $1.9M-77.9% | $2.4M-75.6% | $3.0M-73.5% | $3.8M-62.7% | $8.8M-32.4% | $9.9M+21.1% | $11.2M+54.5% | $10.2M+69.4% | $13.0M+1579.0% | $8.2M+4281.3% |
What long-term debt means
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.
More INNOVATION PHARMACEUTICAL financials
Frequently Asked Questions
What was INNOVATION PHARMACEUTICAL's long-term debt in fiscal year 2023?
INNOVATION PHARMACEUTICAL held $1.5M in cash and equivalents at the end of fiscal year 2023, and long-term debt is not reported for that period.
What does long-term debt mean on a financial statement?
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what INNOVATION PHARMACEUTICAL (IPIX) reported on that line in every period on record.